New anti-cancer peptide vaccines and inhibitors developed

24 septiembre 2014

Two new anticancer peptide vaccines and two peptide inhibitors have been developed as part of a larger peptide immunotherapy effort. The vaccines and inhibitors are designed to target the HER-3 and IGF-1R receptors, which are over-expressed in cancers of the breast, pancreas, esophagus and colon.